A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients

NCT06418659 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma

Interventions

DRUG: CD-801

Sponsor

Shanghai Changzheng Hospital